title: Heading back to the trough (levels of biologics in IBD).
authors.affiliation: Northwestern University Feinberg School of Medicine, Medical Director Digestive Health Clinic, Northwestern Medicine, Chicago, Illinois.
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Hanauer
mesh_terms: D000893:Anti-Inflammatory Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D001688:Biological Products / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000379:methods; D006801:Humans; D007155:Immunologic Factors / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D044967:Serum / Q000737:chemistry*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D001688:Biological Products; D007155:Immunologic Factors